Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways

Biochemical and Biophysical Research Communications - Tập 388 - Trang 172-176 - 2009
Chi-Ming Chan1,2, Jia-You Fang3, Hsin-Huang Lin1, Chi-Yea Yang4, Chi-Feng Hung1
1School of Medicine, Fu Jen Catholic University, Taipei Hsien, Taiwan, ROC
2Department of Ophthalmology, Cardinal Tien Hospital, Taipei Hsien, Taiwan, ROC
3Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan, ROC
4Department of Biotechnology, Vanung University, Taoyuan, Taiwan, ROC

Tài liệu tham khảo

Charteris, 1995, Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment, Br. J. Ophthalmol., 79, 953, 10.1136/bjo.79.10.953 Cardillo, 1997, Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome, Ophthalmology, 104, 1166, 10.1016/S0161-6420(97)30167-5 Campochiaro, 1997, Pathogenic mechanisms in proliferative vitreoretinopathy, Arch. Ophthalmol., 115, 237, 10.1001/archopht.1997.01100150239014 Charteris, 2002, Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology, Eye, 16, 369, 10.1038/sj.eye.6700194 Hiscott, 1999, Matrix and the retinal pigment epithelium in proliferative retinal disease, Prog. Retin. Eye. Res., 18, 167, 10.1016/S1350-9462(98)00024-X Kon, 1999, Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study, Invest. Ophthalmol. Vis. Sci., 40, 705 Robbins, 1994, Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases, Invest. Ophthalmol. Vis. Sci., 35, 3649 Cassidy, 1998, Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders, Br. J. Ophthalmol., 82, 181, 10.1136/bjo.82.2.181 Briggs, 2000, Active scatter factor (HGF/SF) in proliferative vitreoretinal disease, Invest. Ophthalmol. Vis. Sci., 41, 3085 Bendich, 1989, Biological actions of carotenoids, FASEB J., 3, 1927, 10.1096/fasebj.3.8.2656356 Chew, 2004, Carotenoid action on the immune response, J. Nutr., 134, 257S, 10.1093/jn/134.1.257S Agarwal, 2000, Tomato lycopene and its role in human health and chronic diseases, CMAJ, 163, 739 Hwang, 2006, Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells, Exp. Biol. Med. (Maywood), 231, 322, 10.1177/153537020623100313 Voutilainen, 2006, Carotenoids and cardiovascular health, Am. J. Clin. Nutr., 83, 1265, 10.1093/ajcn/83.6.1265 Khachik, 2002, Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health, Exp. Biol. Med. (Maywood), 227, 845, 10.1177/153537020222701002 Bernstein, 2001, Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye, Exp. Eye Res., 72, 215, 10.1006/exer.2000.0954 Chiang, 2007, Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB, Life Sci., 81, 1509, 10.1016/j.lfs.2007.09.018 Wu, 2007, Inhibitory effect of lycopene on PDGF-BB-induced signalling and migration in human dermal fibroblasts: a possible target for cancer, Biochem. Soc. Trans., 35, 1377, 10.1042/BST0351377 Nguyen, 1999, Lycopene: chemical and biological properties, Food Technol., 53, 38 Stahl, 2005, Bioactivity and protective effects of natural carotenoids, Biochim. Biophys. Acta, 1740, 101, 10.1016/j.bbadis.2004.12.006 Nilsson, 2003, Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage, Doc. Ophthalmol., 106, 13, 10.1023/A:1022419606629 Snodderly, 1995, Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins, Am. J. Clin. Nutr., 62, 1448S, 10.1093/ajcn/62.6.1448S Jin, 2000, Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha, Invest. Ophthalmol. Vis. Sci., 41, 4324 Casaroli Marano, 1994, The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy, Invest. Ophthalmol. Vis. Sci., 35, 2791 Scheiffarth, 1988, Proteins of the extracellular matrix in vitreoretinal membranes, Graefes Arch. Clin. Exp. Ophthalmol., 226, 357, 10.1007/BF02172967 Hinton, 1998, Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells, Exp. Cell Res., 239, 11, 10.1006/excr.1997.3873 Smith-Thomas, 1996, Additive effects of extra cellular matrix proteins and platelet derived mitogens on human retinal pigment epithelial cell proliferation and contraction, Curr. Eye Res., 15, 739, 10.3109/02713689609003457 Haugland, 1997, Adhesion and migration of human glioma cells are differently dependent on extracellular matrix molecules, Anticancer Res., 17, 1035 Wagner, 1995, Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins, Curr. Eye Res., 14, 373, 10.3109/02713689508999935 Powell, 1996, Matrix-specific effect of endothelial control of smooth muscle cell migration, J. Vasc. Surg., 24, 51, 10.1016/S0741-5214(96)70144-1 Lo, 2007, Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells, Biochem. Pharmacol., 74, 54, 10.1016/j.bcp.2007.03.017